Prenatal and family risks of children born to mothers with epilepsy: Effects on cognitive development

Developmental Medicine and Child Neurology

Volumn 50, Issue 2, 2008, Pages 117-122

  Titze, Karl ^a   Koch, Sabine ^b   Helge, Hans ^c   Lehmkuhl, Ulrike ^c   Rauh, Hellgard ^d   Steinhausen, Hans Christoph ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN HYPOXIA; COGNITIVE DEVELOPMENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG WITHDRAWAL; EPILEPSY; FAMILY LIFE; FEMALE; GRAND MAL SEIZURE; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREDICTION; PREGNANCY DISORDER; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SOCIOECONOMICS; TERATOGENICITY;

ADOLESCENT; ADULT; ANTICONVULSANTS; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT; CHILD OF IMPAIRED PARENTS; COGNITION; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOXIA, BRAIN; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SEIZURES; SOCIOECONOMIC FACTORS; TERATOGENS;

EID: 38349059230     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2007.02020.x     Document Type: Article

References (34)

1. Yerby MS, Collins SD. Teratogenicity of antiepileptic drugs. In: Engel J, Pedley TA, editors. Epilepsy: A Comprehensive Textbook. Philadephia: Lippincott-Raven, 1997: 1195-203.
2. Dessens AB, Cohen-Kettenis PT, Mellenbergh G-J, van de Poll NE, Koppe JG, Boer K. Prenatal exposure to anticonvulsants and psychosexual development. Arch Sex Behav 1999; 28: 31-44.
3. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproat syndrome and autism: Additional evidence of an association. Dev Med Child Neurol 2001; 43: 202-06.
4. Dessens AB, Boer K, Koppe JG, van de Poll NE, Cohen-Kettenis PT. Studies on long-lasting consequences of prenatal exposure to anticonvulsant drugs. Acta Paediatr 1994; 404: 54-64.
5. Engel J, Pedley TA. Epilepsy: A Comprehensive Textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998.
6. Gaily E, Kantola-Scorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990; 32: 403-14.
7. Lösche G, Steinhausen H-C, Koch S, Helge H. The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 1994; 83: 961-66.
8. Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies. In:
9. Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, editors. Epilepsy, Pregnancy and the Child. New York: Raven Press, 1982: 53-60.
10. The EURAP Study Group. Seizure control and treatment in pregnancy. Observations from the EURAP Epilepsy Pregnancy Registry. Neurology 2006; 66: 354-60.
11. Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database of Systematic Reviews. No: CD004848, 2004.
12. Eriksson K, Viinikainen K, Mönkkönen A, et al. Children exposed to valproat in utero. Population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005; 65: 189-200.
13. Gaily E, Kantola-Scorsa E, Hiilesmaa VK, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62: 28-32.
14. Hanson JW, Myrianthopoulos NC, Sedgwick MA, Smith H, Smith DW. Risk of the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Paediatr Child Health 1976; 89: 662-68.
15. Koch S, Titze K, Zimmermann RB, Schröder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999; 40: 1237-43.
16. Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274: 1518-25.
17. Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64: 949-54.
18. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271: 767-70.
19. van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy: Late effects on the childrens CNS development. Am J Obstet Gynecol 1991; 164: 121-28.
20. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van de Poll NE, Boer K. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr 2000; 89: 533-41.
21. Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the develpment of birth defects. Lancet 1976; 7: 272-75.
22. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers of with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 1575-83.
23. Kalmár M. The course of intellectual development in preterm and fullterm children: An 8-year longitudinal study. Int J Behav Dev 1996; 19: 491-516.
24. Steinhausen H-C, Lösche G, Koch S, Helge H. The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr 1994; 83: 955-60.
25. Prechtl HF. Neurological sequelae of prenatal and perinatal complications. Br Med J 1967; 4: 763-67.
26. Ikonomidou C, Scheer I, Wilhelm T, et al. Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol 2007; 11: 297-301.
27. Koch S, Titze K, Zimmer U, Lehmkuhl U, Rauh H, Helge H. Wachstum bei Kindern von Frauen mit Epilepsie und Antiepileptika-Therapie während der Schwangerschaft. Monatsschrift für Kinderheilkunde 2004; 152: 1321-26.
28. Koch S, Titze K, Treuter S, et al. Maternal use of valproate during pregnancy: Risk of major malformations and brain disorders. In: Schmitz B, Sander T, editors. Juvenile Myoclonic Epilepsy: The Janz-Syndrom. Petersfield, UK: Wrightson Biomedical Publishing, 2000: 121-28.
29. Caldwell BM, Bradley RH. HOME-Scale: Home observation of the environment. Kansas: University of Kansas, 1980.
30. Schuck K-D, Eggert D. HAWIVA (Hannover-Wechsler-Intelligenztest für das Vorschulalter). Deutsche Bearbeitung der Wechsler Preschool and Primary Scale of Intelligence. Experimentalform. Göttingen: Hans Huber, 1975. (In German.).
31. Tewes U. HAWIK-R. Hamburg Wechsler Intelligenztest für Kinder, Revision 1983. Handbuch. Bern: Verlag Hans Huber, 1985.
32. Tewes U. Hamburg-Wechsler Intelligenztest für Erwachsene - Revision. Bern: Huber, 1991.
33. Arbuckle JL. AMOS 7.0 User's Guide. Spring House, PA: Amos Development Corporation, 1991.
34. Gaily E, Kantola-Scorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990; 32: 403-14.